Long Non Coding RNAs as Prognostic Factors or Diagnostic Biomarkers of Renal Transplant Rejection: A Systematic Review and Meta Analysis
Urology Journal,
Vol. 22 No. 06 (2025),
11 January 2026
,
Page 261-268
https://doi.org/10.22037/uj.v22i.8503
Abstract
Purpose: Acute rejection (AR) of a kidney graft in renal transplant recipients is associated with microvascular injury leading to graft dysfunction and failure. Long noncoding RNAs (lncRNAs) may serve as markers for vascular injury and AR. We aimed to identify lncRNA biomarkers associated with graft loss after renal transplantation.
Materials and Methods: We searched PubMed, Scopus, Embase, and Web of Science. Odds ratios (ORs), hazard ratios (HRs), and their 95% confidence intervals (95% CIs) were calculated to assess effect sizes. All graphical designs and statistical analyses were performed using STATA version 17 (StataCorp LP, College Station, TX, USA) and the meta package.
Results: Of 291 initially identified articles, 10 met eligibility criteria and were included in the systematic review; 3 provided sufficient data for meta‑analysis. The pooled area under the curve (AUC) for lncRNA measurement in diagnosing acute kidney rejection was 0.79 in adults and 0.75 in pediatric populations, indicating good diagnostic accuracy. Leave‑one‑out sensitivity analyses confirmed the stability of these findings. However, the pooled HR for the prognostic value of lncRNAs was 0.81 (95% CI: 0.63–1.04), which was not statistically significant.
Conclusion: Assessment of lncRNA levels in plasma or urine appears promising as a diagnostic biomarker for acute kidney rejection. The prognostic value of lncRNAs in the course of acute kidney rejection requires further evaluation.
- long noncoding RNAs (lncRNAs)
- 3-Dimensional (3D) technology, Percutaneous Nephrolithotomy, Renal stone.
- Biomarker
How to Cite
References
1 Mange, K. C., Joffe, M. M., Feldman, H. I. Effect of the use or nonuse of long-term dialysis on the subsequent survival of renal transplants from living donors. N Engl J Med 344, 726–731 (2001).
2 Schwarz, A., et al. Safety and adequacy of renal transplant protocol biopsies. Am J Transplant 5, 1992–1996 (2005).
3 Zhao, X., Chen, J., Ye, L., Xu, G. Serum metabolomics study of the acute graft rejection in human renal transplantation based on liquid chromatography–mass spectrometry. J Proteome Res 13, 2659–2667 (2014).
4 Narouie, B., Saatchi, M. Short term and Long term Survival Rate and Risk Factors of Graft Rejection after Deceased Donor Kidney Transplantation: A Systematic Review and Meta-Analysis. Transl Res Urol 3, 95–114 (2021). https://doi.org/10.22034/tru.2021.284800.1066
5 Nankivell, B. J., Alexander, S. I. Rejection of the kidney allograft. N Engl J Med 363, 1451–1462 (2010).
6 Lebranchu, Y., et al. Pretransplant identification of acute rejection risk following kidney transplantation. Transpl Int 27, 129–138 (2014).
7 Wu, K., et al. The severity of acute cellular rejection defined by Banff classification is associated with kidney allograft outcomes. Transplantation 97, 1146–1154 (2014).
8 Shang, Y., et al. Performance of polymerase chain reaction techniques detecting perforin in the diagnosis of acute renal rejection: a meta-analysis. PLoS One 7, e39610 (2012).
9 Mohammadi, A., Nikoobakht, M. R., Hosseini, S. R. Urolithiasis in Renal Transplantation Patients: An Update of the Literature. Transl Res Urol 3, 149–153 (2021). https://doi.org/10.22034/tru.2021.305308.1081
10 Ho, J., Wiebe, C., Gibson, I. W., Rush, D. N., Nickerson, P. W. Biomarker Discovery Requirements. Am J Kidney Dis 4, 629–640 (2012).
11 Beckingham, I., Nicholson, M., Bell, P. Analysis of factors associated with complications following renal transplant needle core biopsy. Br J Urol 73, 13–15 (1994).
12 Machida, J., et al. Subcapsular hematoma and hypertension following percutaneous needle biopsy of a transplanted kidney. Int J Urol 3, 228–230 (1996).
13 Huraib, S., et al. Percutaneous needle biopsy of the transplanted kidney: technique and complications. Am J Kidney Dis 14, 13–17 (1989).
14 Tierney, J. F., Stewart, L. A., Ghersi, D., Burdett, S., Sydes, M. R. Practical methods for incorporating summary time-to-event data into meta-analysis. Trials 8, 16 (2007). https://doi.org/10.1186/1745-6215-8-16
15 Chen, W., et al. Microarray analysis of long non-coding RNA expression in human acute rejection biopsy samples following renal transplantation. Mol Med Rep 10, 2210–2216 (2014). https://doi.org/10.3892/mmr.2014.2420
16 Ge, Y. Z., et al. A Molecular Signature of Two Long Non-Coding RNAs in Peripheral Blood Predicts Acute Renal Allograft Rejection. Cell Physiol Biochem 44, 1213–1223 (2017). https://doi.org/10.1159/000485451
17 Groeneweg, K. E., et al. Circulating Long Noncoding RNA LNC-EPHA6 Associates with Acute Rejection after Kidney Transplantation. Int J Mol Sci 21 (2020). https://doi.org/10.3390/ijms21165616
18 Lorenzen, J. M., et al. Long Noncoding RNAs in Urine Are Detectable and May Enable Early Detection of Acute T Cell-Mediated Rejection of Renal Allografts. Clin Chem 61, 1505–1514 (2015). https://doi.org/10.1373/clinchem.2015.243600
19 Nafar, M., et al. Expression Levels of lncRNAs in the Patients with the Renal Transplant Rejection. Urol J 16, 572–577 (2019). https://doi.org/10.22037/uj.v0i0.5456
20 Qiu, J., et al. Transforming growth factor-β activated long non-coding RNA ATB plays an important role in acute rejection of renal allografts and may impact postoperative pharmaceutical immunosuppression therapy. Nephrology (Carlton) 22, 796–803 (2017). https://doi.org/10.1111/nep.12851
21 Xu, J., et al. Long Non-coding RNA Expression Profiling in Biopsy to Identify Renal Allograft at Risk of Chronic Damage and Future Graft Loss. Appl Biochem Biotechnol 190, 660–673 (2020). https://doi.org/10.1007/s12010-019-03082-2
22 Zhang, Z., et al. Identifying 4 Novel lncRNAs as Potential Biomarkers for Acute Rejection and Graft Loss of Renal Allograft. J Immunol Res 2020, 2415374 (2020). https://doi.org/10.1155/2020/2415374
23 Zou, Y., Zhang, W., Zhou, H. H., Liu, R. Analysis of long noncoding RNAs for acute rejection and graft outcome in kidney transplant biopsies. Biomark Med 13, 185–195 (2019). https://doi.org/10.2217/bmm-2018-0272
24 Kölling, M., et al. Circular RNA in urine—liquid biopsy biomarker of acute rejection in kidney transplantation. J Am Soc Nephrol 30, 409 (2019).
25 Chand, S., et al. The spectrum of renal allograft failure. PLoS One 11, e0162278 (2016).
26 Clayton, P. A., McDonald, S. P., Russ, G. R., Chadban, S. J. Long-term outcomes after acute rejection in kidney transplant recipients: an ANZDATA analysis. J Am Soc Nephrol 30, 1697–1707 (2019).
27 Bruneau, S., et al. Key features of the intragraft microenvironment that determine long-term survival following transplantation. Front Immunol 3, 54 (2012).
28 Contreras, A. G., Briscoe, D. M. Every allograft needs a silver lining. J Clin Invest 117, 3645–3648 (2007).
29 Denton, M. D., et al. The role of the graft endothelium in transplant rejection: evidence that endothelial activation may serve as a clinical marker for the development of chronic rejection. Pediatr Transplant 4, 252–260 (2000).
30 Reinders, M. E., Fang, J. C., Wong, W., Ganz, P., Briscoe, D. M. Expression patterns of vascular endothelial growth factor in human cardiac allografts: association with rejection. Transplantation 76, 224–230 (2003).
31 Reinders, M. E., Rabelink, T. J., Briscoe, D. M. Angiogenesis and endothelial cell repair in renal disease and allograft rejection. J Am Soc Nephrol 17, 932–942 (2006).
32 Arya, P., et al. The Effect of Pre-Transplant Psychosocial Problems on Kidney Transplantation Outcomes. Transl Res Urol 3, 125–130 (2021). https://doi.org/10.22034/tru.2021.299468.1080
33 Bishop, G. A., Waugh, J. A., Landers, D. V., Krensky, A. M., Hall, B. M. Microvascular destruction in renal transplant rejection. Transplantation 48, 408–414 (1989).
34 Long, D. A., Norman, J. T., Fine, L. G. Restoring the renal microvasculature to treat chronic kidney disease. Nat Rev Nephrol 8, 244–250 (2012).
35 Lorenzen, J. M., Thum, T. Long noncoding RNAs in kidney and cardiovascular diseases. Nat Rev Nephrol 12, 360–373 (2016).
36 Ransohoff, J. D., Wei, Y., Khavari, P. A. The functions and unique features of long intergenic non-coding RNA. Nat Rev Mol Cell Biol 19, 143–157 (2018).
37 Ulitsky, I., Bartel, D. P. lincRNAs: genomics, evolution, and mechanisms. Cell 154, 26–46 (2013).
38 Sani, H. M., Hejazian, M., Khatibi, S. M. H., Ardalan, M., Vahed, S. Z. Long non-coding RNAs: an essential emerging field in kidney pathogenesis. Biomed Pharmacother 99, 755–765 (2018).
39 Shobeiri, P., et al. Circulating long non-coding RNAs as novel diagnostic biomarkers for Alzheimer’s disease (AD): A systematic review and meta-analysis. PLoS One 18, e0281784 (2023).
40 Zou, X.-F., et al. Transplant Proc 1558–1565 (Elsevier).
41 Groeneweg, K. E., et al. Diabetic nephropathy alters circulating long noncoding RNA levels that normalize following simultaneous pancreas–kidney transplantation. Am J Transplant 20, 3451–3461 (2020).
- Abstract Viewed: 237 times
- 8503-pdf Downloaded: 76 times